0
0
Ahmedabad, June 2, 2025 — In a groundbreaking effort to tackle the global menace of antimicrobial resistance (AMR), Dr. Jyot Antani, an associate research scientist at Yale University with roots in Ahmedabad, is pioneering research that uses viruses, specifically bacteriophages, to target and kill drug-resistant bacteria.
Dr. Antani, who studied in Gujarati medium schools before attending IIT Bombay and later earning a PhD from Texas A&M University, is part of a Yale research team exploring how viruses that infect bacteria—known as phages—can be harnessed to fight infections that no longer respond to conventional antibiotics.
A New Approach to an Old Enemy
Bacteriophages, or phages, are viruses that specifically infect bacteria. They attach to bacterial cells, inject their genetic material, and replicate inside, eventually causing the bacterial cell to burst and die. This natural process is being revisited as a potential solution to the rising threat of AMR, which the World Health Organization has called one of the top ten global public health threats facing humanity.
However, understanding the precise interactions between phages and bacteria at a microscopic level has been a significant challenge. Traditional methods for studying these interactions are labor-intensive, time-consuming, and only provide rough estimates.
Breakthrough in Phage-Bacteria Research
To overcome these obstacles, Dr. Antani and his colleagues at the Yale Quantitative Biology Institute developed the Microscopic Phage Adsorption (MPA) assay. This innovative technique uses fluorescent dyes to make phages visible as bright spots under a microscope, allowing researchers to observe and record, in real time, how individual phages attach to bacterial cells.
According to the team’s study, published in the prestigious Proceedings of the National Academy of Sciences (PNAS), the MPA assay enables high-throughput, precise quantification of phage-bacteria interactions. “If the sample shows a stable fluorescent dot, it means that the phage has strongly attached to the host bacteria,” explains Dr. Antani. “Phages bind to specific molecules on the bacterial surface, much like a ship docking at its assigned spot in a harbor.”
The researchers tested the method on various phages and bacteria, including some notorious strains known for their antibiotic resistance, and found it effective in most cases.
An Inspiring Journey
Dr. Antani’s journey from Ahmedabad to Yale is a testament to perseverance and scientific curiosity. Motivated by the COVID-19 pandemic and its aftermath, he shifted his focus to the complex world of bacteria-virus interactions. “There are several interesting projects going on in India in this field, too,” he notes, expressing optimism about global collaboration in the fight against AMR.
The Road Ahead
This breakthrough could pave the way for more targeted and effective phage therapies, offering hope against infections that are currently untreatable with existing antibiotics. As AMR continues to threaten public health worldwide, innovations like the MPA assay represent a crucial step forward.
Disclaimer:
This article is based on information published by the Times of India and the research summary from Yale University. The findings discussed are part of ongoing scientific research and should not be interpreted as established clinical treatments. For medical advice or treatment, please consult a qualified healthcare professional.
Citations:
